The authors describe ongoing clinical trials on druggable targets in TNBC-brain metastasis (BM) for a more targeted treatment and introduce the obstacles hindering drug delivery to the brain, bringing strategies and advancing knowledge for future steps in the treatment of patients with TNBC-BM.
[Drug Discovery Today]